This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

SYNGULON

Thank you for visiting our virtual exhibit

SYNGULON


COMPANY BACKGROUND


Syngulon introduces a new genetic technology (US Patent 9,333,227 / 10,188,114) focusing on the control of microorganisms for recombinant products to solve:


1. Genetic drift
2. Genetic stability
3. Yield increase
4. Ease of use
5. Antibiotic-free selection of expressing clones
ADDED VALUE
The issued patents US Patent 9,333,227 / 10,188,114 are based on the use of bacteriocin/ immunity.
They are part of a new worldwide patent portfolio developed by Syngulon and available for licensing in all fields of use on a non-exclusive base. 

 

CONTACT INFO 

Rue du Bois Saint-Jean 15/1
4102 SERAING
Tel : +32 4 290 55 45
E-mail : contact@syngulon.com
Website : www.syngulon.com
DELEGATE
Guy HELIN, CEO